Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Major Pan-European report highlights stark inequalities in cancer treatment throughout Europe

07.10.2005


A report by the Karolinska Institutet, in conjunction with the Stockholm School of Economics, exposes stark inequalities in patient access to cancer treatment across Europe and urges action by decision makers to redress these inequalities.



The report, entitled ‘A pan-European comparison regarding patient access to cancer drugs’, found that despite the proven benefits of new innovative treatments options, patients across Europe do not have equality of access to these cancer drugs and the speed at which patients can benefit from them depends to a great extent upon the country in which they live.

Nineteen countries, representing almost 75% of Europe’s population, were included in the report. Austria, Spain, and Switzerland are shown to be the leaders in terms of early adoption and availability of new cancer drugs whereas other countries, such as the UK, Czech Republic, Hungary Norway, and Poland lag behind.


“Patients have to wait too long to obtain the benefits of newer therapies and the biggest hurdle to the uptake of new drugs is the proactive allocation of financial resources and budget in the health care systems by policy and decision makers”, says Dr. Nils Wilking of the Karolinska Institutet.

Drs Wilking and Jönsson point out that the total healthcare cost for cancer in countries included in this report is an estimated 120 euros per citizen – only 5% of total healthcare expenditure. The cost of cancer drugs per capita ranges from 7 euros to 16 euros per citizen in Europe. Costs associated with inpatient hospital care costs dominate the direct costs of cancer in Europe, accounting for 60% to 94% of all costs and less than 10% is spent on drugs. The share of health care costs for cancer is much less than the share of burden of the disease.

“A superior approach for cancer patients in Europe would be to take a broader perspective on the benefits and costs these drugs bring to patients and society, and introduce a more rational system of allocation of resources to the healthcare system,” explained Dr. Bengt Jönsson of the Stockholm School of Economics. “It is worth emphasising that new treatments are usually targeted to specifically identifiable populations” ‘he continued. Dr Jönsson also added “There are examples of best practice in some countries which try to expedite patient access to innovative therapies - these should be assessed on their applicability for more countries in Europe.”

The report also argues that while new therapies generally increase health expenditure, the value they bring to patients in terms of survival and treating their cancer must be recognized. Research undertaken in the U.S. by Dr. Frank Lichtenberg of Columbia University suggests that access to more and newer cancer drugs improves survival rates.

For further information, please contact:
Nils Wilking, mobile +46 73 625 17 19, e-mail: nils.wilking@telia.com

Bengt Jönsson, mobile +46 70 847 03 63, e-mail Bengt.Jonsson@hhs.se

Sabina Bossi | alfa
Further information:
http://info.ki.se/new_uploads/Cancer%20Report(1).pdf
http://www.ki.se

More articles from Health and Medicine:

nachricht Team discovers how bacteria exploit a chink in the body's armor
20.01.2017 | University of Illinois at Urbana-Champaign

nachricht Rabies viruses reveal wiring in transparent brains
19.01.2017 | Rheinische Friedrich-Wilhelms-Universität Bonn

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>